Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Contents 1. INTRODUCTION 1 2. CONTEXT = Commercial Stakes and the IPR Factor ................................................... Intellectual Property Rights in the United States and Japan 11 Intellectual Property Issues Raised by Biotechnology 15 3. THE EXPERIENCE OF U.S. FIRMS IN JAPAN ..... Jananese Case Law ................................................. Genentech and T-PA .................................................. ....17 ....17 .. 20 4. JAPAN'S GROWING PRESENCE IN THE UNITED STATES 24 Strategies of Japanese Companies 24 Japanese Corporate Involvement in U.S. Academic Research 27 Japanese Corporate Experience with U.S. Patent Litigation 29 EPO: Amgen vs. Genetics Institute and Chugai 32 5. FUTURE PROSPECTS AND POLICY CONSIDERATIONS FOR THE UNITED STATES .................. Bilateral Issues.................................... International Patent Harmonization ... Trade-related Issues............................ 12 ~ at.. ~ ~ ti mn Competitive Implications for U.S. Biotechnology IX .34 .34 .36 .38 .40 .41
